Latest News

Business
Regeneron Acquires 23andMe for $256 Million Amid Bankruptcy, Assumes Control of DNA Data Operations
Regeneron Pharmaceuticals has announced its acquisition of genetic testing company 23andMe for $256 million through a bankruptcy auction, marking a significant expansion of its footprint into consumer genetics. The deal, […]








